Why You Can’t Always Trust the Cannabis Label
With inconsistent testing and market pressures, the numbers don’t always tell the whole story.
With inconsistent testing and market pressures, the numbers don’t always tell the whole story.
The information presented in this primer is intended to help doctors and patients understand if and when drug interactions with cannabis are likely.
MedicateOH sat down with Dr. Sinharoy to learn more about what he’s doing to assist Ohio patients.
Cannabis has a huge variety of effects, meaning that what could be useful for one person could be completely different for another person.
Gastrointestinal (GI) illnesses are a frequent reason for using medical cannabis. These conditions include gastroesophageal reflux disease (GERD), two inflammatory bowel diseases — Crohn’s disease and ulcerative colitis — and irritable bowel syndrome (IBS).
MedicateOH is dedicated to supplying Ohioans with educational and useful news and information to make thoughtful medical decisions involving their holistic health.
Research: A Patient Survey
The medical cannabis market is well rooted and growing like mad, at least in North America.
Acquired immune deficiency syndrome (AIDS/HIV), Alzheimer’s disease, Amyotrophic lateral sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Chronic traumatic encephalopathy (CTE), Crohn’s disease, Epilepsy or another seizure disorder, Fibromyalgia, Glaucoma, Hepatitis C, Inflammatory bowel disease, Multiple sclerosis, Parkinson’s disease, Post-traumatic stress disorder (PTSD), Sickle cell anemia, Spinal cord disease or injury, Tourette’s syndrome, Traumatic brain injury (TBI), Ulcerative colitis